These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 20398629)
21. Transforming growth factor-beta receptor inhibition enhances adenoviral infectability of carcinoma cells via up-regulation of Coxsackie and Adenovirus Receptor in conjunction with reversal of epithelial-mesenchymal transition. Lacher MD; Tiirikainen MI; Saunier EF; Christian C; Anders M; Oft M; Balmain A; Akhurst RJ; Korn WM Cancer Res; 2006 Feb; 66(3):1648-57. PubMed ID: 16452224 [TBL] [Abstract][Full Text] [Related]
22. AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling. Kong B; Michalski CW; Hong X; Valkovskaya N; Rieder S; Abiatari I; Streit S; Erkan M; Esposito I; Friess H; Kleeff J Oncogene; 2010 Sep; 29(37):5146-58. PubMed ID: 20581862 [TBL] [Abstract][Full Text] [Related]
23. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806 [TBL] [Abstract][Full Text] [Related]
24. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells. Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666 [TBL] [Abstract][Full Text] [Related]
25. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta. Jazag A; Ijichi H; Kanai F; Imamura T; Guleng B; Ohta M; Imamura J; Tanaka Y; Tateishi K; Ikenoue T; Kawakami T; Arakawa Y; Miyagishi M; Taira K; Kawabe T; Omata M Oncogene; 2005 Jan; 24(4):662-71. PubMed ID: 15592526 [TBL] [Abstract][Full Text] [Related]
26. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325 [TBL] [Abstract][Full Text] [Related]
27. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells. Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988 [TBL] [Abstract][Full Text] [Related]
28. Cooperation between GATA4 and TGF-beta signaling regulates intestinal epithelial gene expression. Belaguli NS; Zhang M; Rigi M; Aftab M; Berger DH Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1520-33. PubMed ID: 17290010 [TBL] [Abstract][Full Text] [Related]
29. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling. Yu Z; Xing Y Biochem Biophys Res Commun; 2006 Feb; 340(3):929-34. PubMed ID: 16410076 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of Smad2 reveals its concerted action with Smad4 in regulating TGF-beta-mediated epidermal homeostasis. Ito Y; Sarkar P; Mi Q; Wu N; Bringas P; Liu Y; Reddy S; Maxson R; Deng C; Chai Y Dev Biol; 2001 Aug; 236(1):181-94. PubMed ID: 11456453 [TBL] [Abstract][Full Text] [Related]
31. SCUBE3 is an endogenous TGF-β receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer. Wu YY; Peck K; Chang YL; Pan SH; Cheng YF; Lin JC; Yang RB; Hong TM; Yang PC Oncogene; 2011 Aug; 30(34):3682-93. PubMed ID: 21441952 [TBL] [Abstract][Full Text] [Related]
32. Interleukin-1R-associated kinase 2 is a novel modulator of the transforming growth factor beta signaling cascade. Mullenders J; Fabius AW; van Dongen MM; Kuiken HJ; Beijersbergen RL; Bernards R Mol Cancer Res; 2010 Apr; 8(4):592-603. PubMed ID: 20332216 [TBL] [Abstract][Full Text] [Related]
33. TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Katsuno Y; Lamouille S; Derynck R Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193 [TBL] [Abstract][Full Text] [Related]
34. PRSS14/Epithin is induced in macrophages by the IFN-γ/JAK/STAT pathway and mediates transendothelial migration. Lee D; Lee HS; Yang SJ; Jeong H; Kim DY; Lee SD; Oh JW; Park D; Kim MG Biochem Biophys Res Commun; 2011 Feb; 405(4):644-50. PubMed ID: 21295011 [TBL] [Abstract][Full Text] [Related]
35. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases. Cheng H; Fukushima T; Takahashi N; Tanaka H; Kataoka H Cancer Res; 2009 Mar; 69(5):1828-35. PubMed ID: 19223533 [TBL] [Abstract][Full Text] [Related]
36. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer. Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743 [TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Nawshad A; Lagamba D; Polad A; Hay ED Cells Tissues Organs; 2005; 179(1-2):11-23. PubMed ID: 15942189 [TBL] [Abstract][Full Text] [Related]
38. TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells. Sengupta S; Jana S; Bhattacharyya A Cell Signal; 2014 Feb; 26(2):240-52. PubMed ID: 24269534 [TBL] [Abstract][Full Text] [Related]
39. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer. Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934 [TBL] [Abstract][Full Text] [Related]
40. Shedding of epithin/PRSS14 is induced by TGF-β and mediated by tumor necrosis factor-α converting enzyme. Lee HS; Park BM; Cho Y; Kim S; Kim C; Kim MG; Park D Biochem Biophys Res Commun; 2014 Oct; 452(4):1084-90. PubMed ID: 25245289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]